Sequana Medical NV
XBRU:SEQUA

Watchlist Manager
Sequana Medical NV Logo
Sequana Medical NV
XBRU:SEQUA
Watchlist
Price: 0.93 EUR 3.33%
Market Cap: 37.4m EUR
Have any thoughts about
Sequana Medical NV?
Write Note

Intrinsic Value

SEQUA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one SEQUA stock under the Base Case scenario is 1.7 EUR. Compared to the current market price of 0.93 EUR, Sequana Medical NV is Undervalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SEQUA Intrinsic Value
1.7 EUR
Undervaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Sequana Medical NV

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SEQUA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SEQUA?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Sequana Medical NV

Provide an overview of the primary business activities
of Sequana Medical NV.

What unique competitive advantages
does Sequana Medical NV hold over its rivals?

What risks and challenges
does Sequana Medical NV face in the near future?

Has there been any significant insider trading activity
in Sequana Medical NV recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sequana Medical NV.

Provide P/S
for Sequana Medical NV.

Provide P/E
for Sequana Medical NV.

Provide P/OCF
for Sequana Medical NV.

Provide P/FCFE
for Sequana Medical NV.

Provide P/B
for Sequana Medical NV.

Provide EV/S
for Sequana Medical NV.

Provide EV/GP
for Sequana Medical NV.

Provide EV/EBITDA
for Sequana Medical NV.

Provide EV/EBIT
for Sequana Medical NV.

Provide EV/OCF
for Sequana Medical NV.

Provide EV/FCFF
for Sequana Medical NV.

Provide EV/IC
for Sequana Medical NV.

Show me price targets
for Sequana Medical NV made by professional analysts.

What are the Revenue projections
for Sequana Medical NV?

How accurate were the past Revenue estimates
for Sequana Medical NV?

What are the Net Income projections
for Sequana Medical NV?

How accurate were the past Net Income estimates
for Sequana Medical NV?

What are the EPS projections
for Sequana Medical NV?

How accurate were the past EPS estimates
for Sequana Medical NV?

What are the EBIT projections
for Sequana Medical NV?

How accurate were the past EBIT estimates
for Sequana Medical NV?

Compare the revenue forecasts
for Sequana Medical NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sequana Medical NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sequana Medical NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sequana Medical NV compared to its peers.

Compare the P/E ratios
of Sequana Medical NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Sequana Medical NV with its peers.

Analyze the financial leverage
of Sequana Medical NV compared to its main competitors.

Show all profitability ratios
for Sequana Medical NV.

Provide ROE
for Sequana Medical NV.

Provide ROA
for Sequana Medical NV.

Provide ROIC
for Sequana Medical NV.

Provide ROCE
for Sequana Medical NV.

Provide Gross Margin
for Sequana Medical NV.

Provide Operating Margin
for Sequana Medical NV.

Provide Net Margin
for Sequana Medical NV.

Provide FCF Margin
for Sequana Medical NV.

Show all solvency ratios
for Sequana Medical NV.

Provide D/E Ratio
for Sequana Medical NV.

Provide D/A Ratio
for Sequana Medical NV.

Provide Interest Coverage Ratio
for Sequana Medical NV.

Provide Altman Z-Score Ratio
for Sequana Medical NV.

Provide Quick Ratio
for Sequana Medical NV.

Provide Current Ratio
for Sequana Medical NV.

Provide Cash Ratio
for Sequana Medical NV.

What is the historical Revenue growth
over the last 5 years for Sequana Medical NV?

What is the historical Net Income growth
over the last 5 years for Sequana Medical NV?

What is the current Free Cash Flow
of Sequana Medical NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sequana Medical NV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sequana Medical NV

Current Assets 7.1m
Cash & Short-Term Investments 4.2m
Receivables 959k
Other Current Assets 2m
Non-Current Assets 3.6m
Long-Term Investments 97.7k
PP&E 3.5m
Current Liabilities 17.5m
Accounts Payable 2m
Accrued Liabilities 2.2m
Other Current Liabilities 13.3m
Non-Current Liabilities 12.9m
Long-Term Debt 12.3m
Other Non-Current Liabilities 641.9k
Efficiency

Earnings Waterfall
Sequana Medical NV

Revenue
433.5k EUR
Cost of Revenue
-4.1m EUR
Gross Profit
-3.6m EUR
Operating Expenses
-19.4m EUR
Operating Income
-23m EUR
Other Expenses
-4.1m EUR
Net Income
-27.2m EUR

Free Cash Flow Analysis
Sequana Medical NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SEQUA Profitability Score
Profitability Due Diligence

Sequana Medical NV's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional Revenue Growth Forecast
Exceptional ROE
ROE is Increasing
42/100
Profitability
Score

Sequana Medical NV's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

SEQUA Solvency Score
Solvency Due Diligence

Sequana Medical NV's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
24/100
Solvency
Score

Sequana Medical NV's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SEQUA Price Targets Summary
Sequana Medical NV

Wall Street analysts forecast SEQUA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SEQUA is 4.31 EUR with a low forecast of 2.93 EUR and a high forecast of 6.3 EUR.

Lowest
Price Target
2.93 EUR
215% Upside
Average
Price Target
4.31 EUR
363% Upside
Highest
Price Target
6.3 EUR
577% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SEQUA?

Click here to dive deeper.

Dividends

Sequana Medical NV
does not pay dividends
Shareholder Yield

Current shareholder yield for SEQUA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SEQUA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Sequana Medical NV Logo
Sequana Medical NV

Country

Belgium

Industry

Health Care

Market Cap

37.4m EUR

Dividend Yield

0%

Description

Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.

Contact

OOST-VLAANDEREN
Ghent
Kortrijksesteenweg 1112, Sint-Denijs-Westrem
+3292928065
www.sequanamedical.com

IPO

2019-02-11

Employees

60

Officers

CEO & Executive Director
Mr. Ian Crosbie
Chief Financial Officer
Ms. Kirsten Van Bockstaele
Director of Investor Relations
Ms. Lies Vanneste
Chief Commercial Officer
Mr. Martijn Blom
Chief Medical Officer
Dr. Oliver Godje M.D., Ph.D.

See Also

Discover More
What is the Intrinsic Value of one SEQUA stock?

The intrinsic value of one SEQUA stock under the Base Case scenario is 1.7 EUR.

Is SEQUA stock undervalued or overvalued?

Compared to the current market price of 0.93 EUR, Sequana Medical NV is Undervalued by 45%.

Back to Top